Star Imaging and Path Lab Limited Gets Empanelled with NIEPA for Medical Services

1 min read     Updated on 22 Jan 2026, 02:50 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Star Imaging and Path Lab Limited has been empanelled by the National Institute of Educational Planning and Administration (NIEPA) to provide medical diagnostic and laboratory services to NIEPA employees at CGHS-approved rates. The empanelment remains valid until the company gets directly empanelled with the Central Government Health Scheme (CGHS). The company disclosed this development as part of regulatory compliance, noting it represents ordinary course of business and does not constitute a material financial impact.

30619234

*this image is generated using AI for illustrative purposes only.

Star imaging and path lab Limited has secured empanelment with the National Institute of Educational Planning and Administration (NIEPA) to provide medical diagnostic and laboratory services. The company announced this development through a regulatory filing dated January 22, 2026, as part of its compliance obligations under SEBI regulations.

Empanelment Details

The empanelment allows Star Imaging and Path Lab Limited to provide comprehensive medical services to NIEPA employees. The key parameters of this arrangement are outlined below:

Parameter: Details
Service Provider: Star Imaging and Path Lab Limited
Empanelling Authority: National Institute of Educational Planning and Administration (NIEPA)
Services Covered: Medical treatment, diagnostic and laboratory services
Pricing Structure: CGHS-approved rates
Validity Period: Until company gets empanelled with CGHS

Service Scope and Pricing

Under this empanelment, the company will provide medical treatment services including diagnostic and laboratory services to NIEPA employees. The services will be charged at Central Government Health Scheme (CGHS)-approved rates, ensuring standardized and regulated pricing for the beneficiaries.

The empanelment demonstrates the company's capability to meet the healthcare service requirements of government institutions and educational organizations. NIEPA, being a premier institute for educational planning and administration, represents a significant institutional client for the company's medical services portfolio.

Regulatory Compliance

The company has made this disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The management has clarified that this empanelment is part of the ordinary course of business and does not constitute a material event that would impact the company's financial position.

The disclosure reflects the company's commitment to transparency and regulatory compliance in informing stakeholders about business developments that may be of interest to investors and market participants.

Historical Stock Returns for Star Imaging And Path Lab

1 Day5 Days1 Month6 Months1 Year5 Years
-1.26%-5.66%-15.72%-42.41%-42.41%-42.41%
Star Imaging And Path Lab
View Company Insights
View All News
like18
dislike

Star Imaging and Path Lab Limited Secures 5-Year Empanelment with Indian National Science Academy

1 min read     Updated on 21 Jan 2026, 02:33 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Star Imaging and Path Lab Limited has secured empanelment with the Indian National Science Academy (INSA) to provide medical diagnostic and laboratory services for a five-year period. The arrangement covers medical treatment for INSA officers, employees, and their dependent family members at CGHS approved rates. The company disclosed this development on January 21, 2026, noting it represents ordinary course business that does not materially impact financial position.

30531804

*this image is generated using AI for illustrative purposes only.

Star Imaging and Path Lab Limited has announced its empanelment with the Indian National Science Academy (INSA) for providing comprehensive medical diagnostic and laboratory services. The company disclosed this development on January 21, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Empanelment Details

The empanelment arrangement encompasses several key aspects that position the company as a healthcare service provider for INSA's stakeholders:

Parameter: Details
Empanelling Authority: Indian National Science Academy (INSA)
Service Scope: Medical diagnostic and laboratory services
Beneficiaries: INSA officers, employees, and dependent family members
Pricing Structure: Central Government Health Scheme (CGHS) approved rates
Validity Period: Five years from empanelment letter date

Service Coverage and Benefits

Under this empanelment, Star Imaging and Path Lab Limited will provide medical treatment services focusing on diagnosis and laboratory testing. The arrangement allows INSA personnel and their families to access the company's healthcare services at standardized government-approved rates, ensuring cost-effective medical care for the beneficiaries.

The five-year validity period provides a stable business opportunity for the company while ensuring continuity of healthcare services for INSA stakeholders. This long-term arrangement reflects confidence in the company's service capabilities and infrastructure.

Regulatory Compliance and Business Impact

The company has emphasized that this empanelment represents business conducted in the ordinary course and does not constitute a material event impacting its financial position. The disclosure has been made as part of regulatory compliance requirements and to maintain transparency with stakeholders.

Company Secretary and Compliance Officer Md Shadab Khan signed the regulatory filing, ensuring proper documentation and compliance with listing obligations. This empanelment adds to the company's portfolio of institutional healthcare partnerships and demonstrates its capability to serve government and academic institutions.

Historical Stock Returns for Star Imaging And Path Lab

1 Day5 Days1 Month6 Months1 Year5 Years
-1.26%-5.66%-15.72%-42.41%-42.41%-42.41%
Star Imaging And Path Lab
View Company Insights
View All News
like15
dislike

More News on Star Imaging And Path Lab

1 Year Returns:-42.41%